Cancer Immunotherapy: Invest in The Future of Cancer Treatment – Loncar Investments – 12.1.15

Immunotherapy, or harnessing the body’s own immune system, is changing the way many cancers are treated. While traditional medicines like chemotherapies often give cancer a broad punch, the benefit of using immunotherapy is derived from the immune system’s dynamic nature and the way it can more precisely be tailored to fight a patient’s disease. Please join us for a webinar introducing the Loncar Cancer Immunotherapy ETF (CNCR), a fund that includes companies that develop these life-saving immunotherapy drugs. Learn more about this potential high growth area within in the biotechnology space and how investors can position themselves to get involved.=
* = Required
Please wait...